Search Result "HER2 overexpression"
MicroRNA and HER2-overexpressing Cancer
Journal: MicroRNA
Volume: 2 Issue: 2 Year: 2013 Page: 137-147
Author(s): Shizhen E. Wang,Ren-Jang Lin
P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2014 Page: 501-510
Author(s): S.M. Donnelly, E. Paplomata, B.M. Peake, E. Sanabria, Z. Chen, R. Nahta
Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2- Overexpressing Metastatic Breast Cancer
Journal: Current Drug Targets
Volume: 14 Issue: 8 Year: 2013 Page: 889-898
Author(s): Yuan Huang,Peifen Fu,Weimin Fan
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 151-162
Author(s): Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. ORegan, Rita Nahta
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 8 Year: 2015 Page: 665-683
Author(s): OtÃlia Menyhart,Libero Santarpia,Balazs Gyorffy
HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 3 Year: 2014 Page: 225-233
Author(s): Teruhiko Fujii,Keisuke Miwa,Tomoyuki Ushijima,Mototsugu Matsunaga,Masaru Fukahori,Kotaro Yuge,Uhi Toh,Nobutaka Iwakuma,Ryuji Takahashi,Hiroki Takahashi,Miki Takenaka,Mai Mishima,Yoshito Akagi,Masayoshi Kage,Shino Nakagawa
Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2999-3019
Author(s): V. Tolmachev
Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 4 Year: 2017 Page: 344-356
Author(s): Heena Singla,Sourav Kalra,Preeti Kheterpal,Vinod Kumar,Anjana Munshi
Anti-HER2 Cancer Therapy and Cardiotoxicity
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 4911-4919
Author(s): Tania Babar, Christopher Blomberg, Eileen Hoffner, Xinhua Yan
Recent Insights into the Development of Preclinical Trastuzumab- Resistant HER2+ Breast Cancer Models
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 17 Year: 2018 Page: 1976-1998
Author(s): Paula Gonzalez-Alonso,Ion Cristobal,Sandra Zazo,Ester Martin-Aparicio,Cristina Chamizo,Juan Madoz-Gurpide,Ana Rovira,Pilar Eroles,Ana Lluch,Joan Albanell,Federico Rojo